Christopher Aled Chamberlain (Christopher A Chamberlain)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Venues

Cancer immunology, immunotherapy : CII

Cancers

Clinical cancer research : an official journal of the American Association for Cancer Research

Biomolecules

National Center for Cancer Immune Therapy

University of Copenhagen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Center for Cancer Immune Therapy Feb 01 2019

Denmark

PhD Student

Education History

University of Copenhagen Feb 01 2019

Denmark

PHD :: Natonal Center for Cancer Immune Therapy (CCIT-DK)

University of Copenhagen - Dec 10 2018

Denmark

MSC :: Center for Cancer Immune Therapy

University of Western Australia

Australia

BSC

Publications

Arianna Draghi, Mario Presti, Agnete Witness Præst Jensen, Christopher Aled Chamberlain, Benedetta Albieri, Anne-Christine K Rasmussen, Mads Hald Andersen, Michael Douglas Crowther, Inge Marie Svane, Marco Donia
Uncoupling CD4+ TIL-mediated tumor killing from JAK-signaling in melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Morten Nielsen, Mario Presti, Zsófia M Sztupinszki, Agnete Witness Præst Jensen, Arianna Draghi, Christopher Aled Chamberlain, Aimilia Schina, Christina Westmose Yde, John B Wojcik, Zoltan Szallasi, Michael Douglas Crowther, Inge Marie Svane, Marco Donia
Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy. Cancer immunology research 10 (10) (2022)
Anders Handrup Kverneland, Christopher Aled Chamberlain, Troels Holz Borch, Morten Nielsen, Sofie Kirial Mørk, Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Lise Pyndt Jørgensen, Lene Buhl Riis, Christina Westmose Yde, Özcan Met, Marco Donia, Inge Marie Svane
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types. Journal for immunotherapy of cancer 9 (10) (2022)
Aishwarya Gokuldass, Arianna Draghi, Krisztian Papp, Troels Holz Borch, Morten Nielsen, Marie Christine Wulff Westergaard, Rikke Andersen, Aimilia Schina, Kalijn Fredrike Bol, Christopher Aled Chamberlain, Mario Presti, Özcan Met, Katja Harbst, Martin Lauss, Samuele Soraggi, Istvan Csabai, Zoltán Szállási, Göran Jönsson, Inge Marie Svane, Marco Donia
Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma. Cancers 12 (11) (2020)
Mario Presti, Marie Christine Wulff Westergaard, Arianna Draghi, Christopher Aled Chamberlain, Aishwarya Gokuldass, Inge Marie Svane, Marco Donia
The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro. Cancer immunology, immunotherapy : CII 70 (6) (2020)
Shane R Stone, Tatjana Heinrich, Suzy M Juraja, Jiulia N Satiaputra, Clinton M Hall, Mark Anastasas, Anna D Mills, Christopher Aled Chamberlain, Scott Winslow, Kristin Priebatsch, Paula T Cunningham, Katrin Hoffmann, Nadia Milech
β-Lactamase Tools for Establishing Cell Internalization and Cytosolic Delivery of Cell Penetrating Peptides. Biomolecules 8 (3) (2018)

Christopher Aled Chamberlain.css-eqlu8i{font-size:small;padding-left:4px;} (Christopher A Chamberlain)

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher Aled Chamberlain (Christopher A Chamberlain)